Integra LifeSciences Holdings Corporation

IART · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$484-$25$19
Dep. & Amort.$39$38$37$38
Deferred Tax-$9-$45-$2-$7
Stock-Based Comp.$6$5$2$7
Change in WC$24-$18-$25-$12
Other Non-Cash-$13$513$1$6
Operating Cash Flow$41$9-$11$51
Investing Activities
PP&E Inv.-$15-$20-$29-$30
Net Acquisitions$0$0$0$4
Inv. Purchases-$0-$2-$7-$4
Inv. Sales/Matur.$0$0$0$35
Other Inv. Act.$0$0$0-$10
Investing Cash Flow-$16-$22-$36-$4
Financing Activities
Debt Repay.-$10-$7$39-$5
Stock Issued$0$0$1$0
Stock Repurch.$0-$0$0-$2
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$14-$5-$0
Financing Cash Flow-$10-$21$35-$7
Forex Effect-$1$13$5-$8
Net Chg. in Cash$14-$21-$7$31
Supplemental Information
Beg. Cash$218$239$246$215
End Cash$232$218$239$246
Free Cash Flow$26-$11-$40$11
Integra LifeSciences Holdings Corporation (IART) Financial Statements & Key Stats | AlphaPilot